US2008167270A1PendingUtilityA1
Anti-infective phosphonate analogs
Est. expiryApr 25, 2023(expired)· nominal 20-yr term from priority
C07F 9/65583A61K 47/548C07F 9/650952C07F 9/6561C07F 9/65586C07F 9/58C07F 9/4006
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention is related to phosphorus substituted anti-infective compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A conjugate or a pharmaceutically acceptable salt or solvate thereof, that is a compound of formula 504:
substituted with one or more groups A 0 , wherein:
A 0 is A 1 , A 2 or W 3 with the proviso that the conjugate includes at least one A 1 ;
Y 1 is independently O, S, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), or N(N(R x )(R x ));
Y 2 is independently a bond, O, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), N(N(R x )(R x )), —S(O) M2 —, or —S(O) M2 —S(O) M2 —; and when Y 2 joins two phosphorous atoms Y 2 can also be C(R 2 )(R 2 );
R x is independently H, R 1 , R 2 , W 3 , a protecting group, or the formula:
R 1 is independently H, W 3 , R 2 or a protecting group;
R 1 is independently H or alkyl of 1 to 18 carbon atoms;
R 2 is independently H, R 1 , R 3 or R 4 wherein each R 4 is independently substituted with 0 to 3 R 3 groups or taken together at a carbon atom, two R 2 groups form a ring of 3 to 8 carbons and the ring may be substituted with 0 to 3 R 3 groups;
R 3 is R 3a , R 3b , R 3c or R 3d , provided that when R 3 is bound to a heteroatom, then R 3 is R 3c or
R 3d
R 3a is F, Cl, Br, I, —CN, N 3 or —NO 2 ;
R 3b is Y 1 ;
R 3c is —R x , —N(R x )(R x ), —SR x , —S(O)R x , —S(O) 2 R x , —S(O)(OR x ), —S(O) 2 (OR x ), —OC(Y 1 )R x , —OC(Y 1 )OR x , —OC(Y 1 )(N(R x )(R x )), —SC(Y 1 )R x , —SC(Y 1 )OR x , —SC(Y 1 )(N(R x )(R x )), —N(R x )C(Y 1 )R x , —N(R x )C(Y 1 )OR x , or —N(R x )C(Y 1 )(N(R x )(R x ));
R 3d is —C(Y 1 )R x , —C(Y 1 )OR x or —C(Y 1 )(N(R x )(R x ));
R 4 is an alkyl of 1 to 18 carbon atoms, alkenyl of 2 to 18 carbon atoms, or alkynyl of 2 to 18 carbon atoms;
R 5 is R 4 wherein each R 4 is substituted with 0 to 3 R 3 groups;
W 3 is W 4 or W 5 ;
W 4 is R 5 , —C(Y 1 )R 5 , —C(Y 1 )W 5 , —SO M2 R 5 , or —SO M2 W 5 ;
W 5 is carbocycle wherein W 5 is independently substituted with 0 to 3 R 2 groups;
W 6 is W 3 independently substituted with 1, 2, or 3 A 3 groups;
M2 is 0, 1 or 2;
M12a is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12;
M12b is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12;
M1a, M1c, and M1d are independently 0 or 1; and
M12c is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12.
3 . The conjugate of claim 2 , or a pharmaceutically acceptable salt or solvate thereof, which has the formula:
[DRUG]-(A 0 ) nn
wherein:
DRUG is a compound of formula 504;
and nn is 1, 2, or 3.
4 . The conjugate of claim 2 which has formula 4 or 5:
wherein:
one A 0 is A 1 .
5 . The conjugate of claim 4 , wherein each A 1 is of the formula:
6 . The conjugate of claim 4 , wherein each A 1 is of the formula:
7 . The conjugate of claim 4 , wherein each A 1 is of the formula:
8 . The conjugate of claim 4 , wherein each A 1 is of the formula:
9 . The conjugate of claim 4 , wherein each A 1 is of the formula:
wherein: W 5a is a carbocycle where W 5a is independently substituted with 0 or 1 R 2 groups.
10 . The conjugate of claim 4 , wherein M12a is 1.
11 . The conjugate of claim 4 , wherein each A 1 is of the formula:
12 . The conjugate of claim 4 , wherein each A 1 is of the formula:
13 . The conjugate of claim 4 , wherein each A 1 is of the formula:
wherein: W 5a is a carbocycle independently substituted with 0 or 1 R 2 groups.
14 . The conjugate of claim 4 , wherein each A 1 is of the formula:
wherein:
Y 2b is O or N(R 2 ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
15 . The conjugate of claim 4 , wherein each A 1 is of the formula:
wherein: W 5a is a carbocycle independently substituted with 0 or 1 R 2 groups.
16 . The conjugate of claim 4 , wherein each A 1 is of the formula:
wherein: W 5a is a carbocycle where W 5a is independently substituted with 0 or 1 R 2 groups.
17 . The conjugate of claim 4 , wherein each A 1 is of the formula:
wherein:
Y 2b is O or N(R 2 ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
18 . The conjugate of claim 2 wherein each A 2 is of the formula:
19 . The conjugate of claim 2 wherein each A 2 is of the formula:
20 . The conjugate of claim 2 wherein each M12b is 1.
21 . The conjugate of claim 20 where M12b is 0, Y 2 is a bond and W 5 is a carbocycle or where W 5 is optionally and independently substituted with 1, 2, or 3 R 2 groups.
22 . The conjugate of claim 2 wherein each A 2 is of the formula:
wherein: W 5a is a carbocycle where W 5a is optionally and independently substituted with 1, 2, or 3 R 2 groups.
23 . The conjugate of claim 22 wherein M12a is 1.
24 . The conjugate of claim 2 wherein each A 2 is selected from phenyl, substituted phenyl, benzyl, substituted benzyl, pyridyl and substituted pyridyl.
25 . The conjugate of claim 2 wherein each A 2 is of the formula:
26 . The conjugate of claim 2 wherein each A 2 is of the formula:
27 . The conjugate of claim 26 wherein M12b is 1.
28 . The conjugate of claim 2 wherein each A 3 is of the formula:
29 . The conjugate of claim 2 wherein each A 3 is of the formula:
30 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S; and
Y 2a is O, N(R x ) or S.
31 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein Y 2b is O or N(R x ).
32 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 2b is O or N(R x ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
33 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 2b is O or N(R x ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
34 . The conjugate of claim 33 wherein M12d is 1.
35 . The conjugate of claim 2 wherein each A 3 is of the formula:
36 . The conjugate of claim 2 wherein each A 3 is of the formula:
37 . The conjugate of claim 36 wherein W 5 is a carbocycle.
38 . The conjugate of claim 2 wherein each A 3 is of the formula:
39 . The conjugate of claim 38 wherein W 5 is phenyl.
40 . The conjugate of claim 39 wherein M12b is 1.
41 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S; and
Y 2a is O, N(R x ) or S.
42 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein Y 2b is O or N(R x ).
43 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 2b is O or N(R x ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
44 . The conjugate of claim 43 wherein R 1 is H.
45 . The conjugate of claim 44 wherein M12d is 1.
46 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein the phenyl carbocycle is substituted with 0, 1, 2, or 3 R 2 groups.
47 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein the phenyl carbocycle is substituted with 0, 1, 2, or 3 R 2 groups.
48 . The conjugate of claim 2 wherein each A 3 is of the formula:
49 . The conjugate of claim 2 wherein each A 3 is of the formula:
50 . The conjugate of claim 2 wherein each A 3 is of the formula:
51 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S; and
Y 2a is O, N(R 2 ) or S.
52 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S;
Y 2b is O or N(R 2 ); and
Y 2 is O, N(R y ) or S.
53 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S;
Y 2b is O or N(R 2 );
Y 2d is O or N(R y ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
54 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 2b is O or N(R 2 ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
55 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein Y 2b is O or N(R 2 ).
56 . The conjugate of claim 2 wherein each A 3 is of the formula:
57 . The conjugate of claim 2 wherein each A 3 is of the formula:
58 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S; and
Y 2a is O, N(R 2 ) or S.
59 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S;
Y 2b is O or N(R 2 ); and
Y 2c is O, N(R y ) or S.
60 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 1a is O or S;
Y 2b is O or N(R 2 );
Y 2d is O or N(R y ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
61 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein:
Y 2b is O or N(R 2 ); and
M12d is 1, 2, 3, 4, 5, 6, 7 or 8.
62 . The conjugate of claim 2 wherein each A 3 is of the formula:
wherein Y 2b is O or N(R 2 ).
63 . The conjugate of claim 3 wherein A 0 is of the formula:
wherein each R is independently alkyl.
64 . The conjugate of claim 3 which has the formula:
or a pharmaceutically acceptable salt or solvate thereof,
wherein:
DRUG is a compound of formula 504:
Y 1 is independently O, S, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), or N(N(R x )(R x ));
Y 2 is independently a bond, O, N(R x ), N(O)(R x ), N(OR x ), N(O)(OR x ), N(N(R x )(R x )), —S(O) M2 —, or —S(O) M2 —S(O) M2 —;
R x is independently H, R 2 , W 3 , a protecting group, or the formula:
R y is independently H, W 3 , R 2 or a protecting group;
R 2 is independently H, R 3 or R 4 wherein each R 4 is independently substituted with 0 to 3 R 3 groups;
R 3 is R 3a , R 3b , R 3c or R 3d , provided that when R 3 is bound to a heteroatom, then R 3 is R 3c or R 3d ;
R 3a is F, Cl, Br, I, —CN, N 3 or —NO 2 ;
R 3b is Y 1 ;
R 3c is R x , —N(R x )(R x ), —SR x , —S(O)R x , —S(O) 2 R x , —S(O)(OR x ), —S(O) 2 (OR x ), —OC(Y 1 )R x , —OC(Y 1 )OR x , —OC(Y 1 )(N(R x )(R x )), —SC(Y 1 )R x , —SC(Y 1 )OR x , —SC(Y 1 )(N(R x )(R x )), —N(R x )C(Y 1 )R x , —N(R x )C(Y 1 )OR x , or —N(R x )C(Y 1 )(N(R x )(R x ));
R 3d is —C(Y 1 )R x , —C(Y 1 )OR x or —C(Y 1 )(N(R x )(R x ));
R 4 is an alkyl of 1 to 18 carbon atoms, alkenyl of 2 to 18 carbon atoms, or alkynyl of 2 to 18 carbon atoms;
R 5 is R 4 wherein each R 4 is substituted with 0 to 3 R 3 groups;
W 3 is W 4 or W 5 ;
W 4 is R 5 , —C(Y 1 )R 5 , —C(Y 1 )W 5 , —SO 2 R 5 , or —SO 2 W 5 ;
W 5 is carbocycle wherein W 5 is independently substituted with 0 to 3 R 2 groups;
M2 is 1, 2, or 3;
M1a, M1c, and M1d are independently 0 or 1;
M12c is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12;
nm is 1, 2, or 3; and
L is a direct bond or a linking group.
65 . The conjugate of claim 64 wherein each R x is of the formula:
Y 1a is O or S; and
Y 2c is O, N(R y ) or S.
66 . The conjugate of claim 64 wherein each R x is of the formula:
Y 1a is O or S; and
Y 2d is O or N(R y ).
67 . The conjugate of claim 64 wherein each R x is of the formula:
68 . The conjugate of claim 65 wherein each R y is independently H or alkyl of 1 to 10 carbons.
69 . The conjugate of claim 64 wherein each R x is of the formula:
70 . The conjugate of claim 64 wherein each R x is of the formula:
71 . The conjugate of claim 64 wherein each R x is of the formula:
72 . The conjugate of claim 64 wherein each Y 1 is O or S.
73 . The conjugate of claim 64 wherein each Y 2 is O, N(R y ) or S.
74 . The conjugate of claim 64 wherein nn is 1.
75 . The conjugate of claim 64 wherein nn is 2.
76 . The conjugate of claim 64 wherein nn is 3.
77 . (canceled)
78 . The conjugate of claim 64 wherein each L has a molecular weight of from about 20 daltons to about 400 daltons.
79 . The conjugate of claim 64 wherein each L has a length of about 5 angstroms to about 300 angstroms.
80 . The conjugate of claim 64 wherein each L separates the compound of 504 and the phosphorous of the phosphonate group by about 5 angstroms to about 200 angstroms, inclusive.
81 . The conjugate of claim 64 wherein each L is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 2 to 25 carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (—O—), and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy.
82 . The conjugate of claim 64 wherein each L is of the formula W-A wherein A is (C 1 -C 24 )alkylene, (C 2 -C 24 )alkenylene, (C 2 -C 24 )alkynylene, (C 3 -C 8 )cycloalkylene, (C 6 -C 10 )aryl or a combination thereof, wherein each W is —N(R)C(═O)—, —C(═O)N(R)—, —OC(═O)—, —C(═O)O—, —O—, —S—, —S(O)—, —S(O) 2 —, —N(R)—, —C(═O)—, —N(R)C═N(R)—N(R)—, —C(R)═N(R)—, —S(O) M2 —N(R)—, —N(R)—S(O) M2 —, or a direct bond; wherein each R is independently H or alkyl of 1 to 10 carbons.
83 . The conjugate of claim 82 wherein each A is alkylene of 1 to 10 carbons.
84 . The conjugate of claim 64 wherein each L is a divalent radical formed from a peptide.
85 . The conjugate of claim 64 wherein each L is a divalent radical formed from an amino acid.
86 . The conjugate of claim 64 wherein each L is a divalent radical formed from poly-L-glutamic acid, poly-L-aspartic acid, poly-L-histidine, poly-L-ornithine, poly-L-serine, poly-L-threonine, poly-L-tyrosine, poly-L-leucine, poly-L-lysine-L-phenylalanine, poly-L-lysine or poly-L-lysine-L-tyrosine.
87 . The conjugate of claim 64 wherein each L is of the formula W—(CH 2 ) n wherein, n is between about 1 and about 10; and W is —N(R)C(═O)—, —C(═O)N(R)—, —OC(═O)—, —C(═O)O—, —O—, —S—, —S(O)—, —S(O) 2 —, —C(═O)—, —N(R)—, —N(R)C═N(R)—N(R)—, —C(R)═N(R)—, —S(O) M2 —N(R)—, —N(R)—S(O) M2 —, or a direct bond; wherein each R is independently H or (C 1 -C 6 )alkyl.
88 . The conjugate of claim 64 wherein each L is methylene, ethylene, or propylene.
89 . The conjugate of claim 64 wherein each L is linked to P at a carbon atom of L.
90 . The conjugate as described in claim 2 , which is isolated and purified.
91 - 102 . (canceled)
103 . A pharmaceutical composition comprising a pharmaceutical excipient and a conjugate as described in claim 2 .
104 . A unit dosage form comprising a conjugate as described in claim 2 ; and a pharmaceutically acceptable excipient.
105 . A method for inhibiting an infection in vitro or in vivo comprising contacting a sample in need of such treatment with a conjugate as described in claim 2 .
106 . (canceled)
107 . A method of treating infection in a mammal, comprising administering a conjugate as described in claim 2 to the mammal.
108 - 109 . (canceled)
110 . The compound:
or a pharmaceutically acceptable salt or solvate thereof.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.